Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Montgomery

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|January 19, 2018
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer's disease in JapanWilliam Montgomery, Kaname Ueda, Margaret Jorgensen, et al.
Neuropsychiatric Disease and Treatment|March 7, 2014
Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other propertiesJingping Zhao, Jianjun Ou, Haibo Xue, et al.
Pharmacopsychiatry|February 17, 2017
Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative SymptomsDiego Novick, William Montgomery, Tamas Treuer, et al.
Neuropsychiatric Disease and Treatment|May 31, 2014
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature reviewHai Bo Haber Xue, Li Liu, Hena Zhang, et al.
BMC Research Notes|January 14, 2009
Medication adherence levels and differential use of mental-health services in the treatment of schizophreniaHaya Ascher-Svanum, Baojin Zhu, Douglas E Faries, et al.
Neuropsychiatric Disease and Treatment|February 6, 2015
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational studyDiego Novick, Jihyung Hong, William Montgomery, et al.
BMC Psychiatry|August 5, 2015
Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational studyDiego Novick, William Montgomery, Tamas Treuer, et al.
Patient Preference and Adherence|March 21, 2015
Antidepressant medication treatment patterns in Asian patients with major depressive disorderDiego Novick, William Montgomery, Victoria Moneta, et al.
Neuropsychiatric Disease and Treatment|January 30, 2015
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapineWilliam Montgomery, Zbigniew Kadziola, Wenye Ye, et al.
International Psychogeriatrics|November 5, 2014
Impact of painful physical symptoms on depression outcomes in elderly Asian patientsDiego Novick, William Montgomery, Jordan Bertsch, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Clinicoeconomics and Outcomes Research : CEOR|January 19, 2018
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer's disease in JapanWilliam Montgomery, Kaname Ueda, Margaret Jorgensen, et al.
Neuropsychiatric Disease and Treatment|March 7, 2014
Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other propertiesJingping Zhao, Jianjun Ou, Haibo Xue, et al.
Pharmacopsychiatry|February 17, 2017
Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative SymptomsDiego Novick, William Montgomery, Tamas Treuer, et al.
Neuropsychiatric Disease and Treatment|May 31, 2014
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature reviewHai Bo Haber Xue, Li Liu, Hena Zhang, et al.
BMC Research Notes|January 14, 2009
Medication adherence levels and differential use of mental-health services in the treatment of schizophreniaHaya Ascher-Svanum, Baojin Zhu, Douglas E Faries, et al.
Neuropsychiatric Disease and Treatment|February 6, 2015
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational studyDiego Novick, Jihyung Hong, William Montgomery, et al.
BMC Psychiatry|August 5, 2015
Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational studyDiego Novick, William Montgomery, Tamas Treuer, et al.
Patient Preference and Adherence|March 21, 2015
Antidepressant medication treatment patterns in Asian patients with major depressive disorderDiego Novick, William Montgomery, Victoria Moneta, et al.
Neuropsychiatric Disease and Treatment|January 30, 2015
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapineWilliam Montgomery, Zbigniew Kadziola, Wenye Ye, et al.
International Psychogeriatrics|November 5, 2014
Impact of painful physical symptoms on depression outcomes in elderly Asian patientsDiego Novick, William Montgomery, Jordan Bertsch, et al.
Pageof 9